NMC Health PLC (LON:NMC) has earned a consensus rating of “Buy” from the six analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is GBX 3,888 ($50.80).
Several analysts have issued reports on the company. Goldman Sachs Group boosted their target price on NMC Health from GBX 4,230 ($55.27) to GBX 4,240 ($55.40) and gave the company a “buy” rating in a research note on Monday, March 25th. Berenberg Bank lowered their target price on NMC Health from GBX 4,700 ($61.41) to GBX 3,600 ($47.04) and set a “buy” rating on the stock in a research note on Friday, May 3rd. Finally, Barclays restated an “overweight” rating on shares of NMC Health in a research note on Monday, March 11th.
NMC stock opened at GBX 2,491 ($32.55) on Tuesday. The company has a debt-to-equity ratio of 150.61, a quick ratio of 1.16 and a current ratio of 1.45. NMC Health has a 1-year low of GBX 2,110 ($27.57) and a 1-year high of GBX 4,376 ($57.18). The firm has a market capitalization of $5.20 billion and a price-to-earnings ratio of 20.97.
NMC Health Company Profile
NMC Health Plc provides healthcare services in the United Arab Emirates, Spain, and internationally. The company operates through two businesses, NMC Healthcare and NMC Trading. It owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.
Further Reading: What are Bollinger Bands?
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.